Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02476838 · ClinicalTrials.gov registry record · NA

Hand Transplantation

A NA study of Amputation, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02476838 is a NA study of Amputation that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 131-participant average among 65 other Amputation trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02476838, a NA study of Amputation, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if an investigational surgery that transfers tissue from a non-living donor to living individual will help restore greater function, appearance, and sensation to the hand and forearm areas of individuals who have suffered traumatic injury to the hand and forearm. This procedure is called a hand allotransplantation or "hand transplant". This study will also collect data on how patients do during and after having a hand transplant from a nonliving donor. Recovery and outcomes will be observed through clinical exams, x-rays, blood and tissue tests, and other associated evaluations at all follow up visits.

Conditions Studied

Interventions

  • PROCEDURE Hand Transplantation

Study Locations (1)

New York

  • NYU Langone Ambulatory Care Center - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-06-02
Est. Completion 2029-01-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02476838

The ClinicalTrials.gov registry entry for NCT02476838 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 131-participant average among 65 other Amputation trials with a reported enrollment target (24% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Hand Transplantation is the first listed.

NCT02476838 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02476838 about?

NCT02476838 is a clinical study titled "Hand Transplantation". The purpose of this study is to see if an investigational surgery that transfers tissue from a non-living donor to living individual will help restore greater function, appearance, and sensation to the hand and forearm areas of individuals who have suffered traumatic injury to the hand and forearm. ...

What is the current status of trial NCT02476838?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2015-06-02. Estimated completion is 2029-01-01.

What conditions does trial NCT02476838 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT02476838?

The interventions under investigation include: Hand Transplantation (PROCEDURE).

Who is sponsoring clinical trial NCT02476838?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02476838 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.